Fonte: Latin American Journal of Pharmacy. Unidade: FCF
Assuntos: FORMAS FARMACÊUTICAS, ANTIPARASITÁRIOS, CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALEXANDRE, Grazielle Prado et al. Determination of Homologous of ivermectin 'H IND. 2''b IND. 1a' And 'H IND. 2''b IND. 1b' in tablets y High performance liquid chromatography coupled to high resolution mass analyzer detector (Q-TOF). Latin American Journal of Pharmacy, v. 33, n. 5, p. 717-724, 2014Tradução . . Disponível em: http://www.latamjpharm.org/resumenes/33/5/LAJOP_33_5_1_2.pdf. Acesso em: 08 nov. 2024.APA
Alexandre, G. P., Mothé, C. M. A., Leite, H. D., Aurora-Prado, M. S., Silva, L. R., Romano, R. L., et al. (2014). Determination of Homologous of ivermectin 'H IND. 2''b IND. 1a' And 'H IND. 2''b IND. 1b' in tablets y High performance liquid chromatography coupled to high resolution mass analyzer detector (Q-TOF). Latin American Journal of Pharmacy, 33( 5), 717-724. Recuperado de http://www.latamjpharm.org/resumenes/33/5/LAJOP_33_5_1_2.pdfNLM
Alexandre GP, Mothé CMA, Leite HD, Aurora-Prado MS, Silva LR, Romano RL, Rondon BD, Singh AK, Kedor-Hackmann ERM, Santoro MIRM. Determination of Homologous of ivermectin 'H IND. 2''b IND. 1a' And 'H IND. 2''b IND. 1b' in tablets y High performance liquid chromatography coupled to high resolution mass analyzer detector (Q-TOF) [Internet]. Latin American Journal of Pharmacy. 2014 ; 33( 5): 717-724.[citado 2024 nov. 08 ] Available from: http://www.latamjpharm.org/resumenes/33/5/LAJOP_33_5_1_2.pdfVancouver
Alexandre GP, Mothé CMA, Leite HD, Aurora-Prado MS, Silva LR, Romano RL, Rondon BD, Singh AK, Kedor-Hackmann ERM, Santoro MIRM. Determination of Homologous of ivermectin 'H IND. 2''b IND. 1a' And 'H IND. 2''b IND. 1b' in tablets y High performance liquid chromatography coupled to high resolution mass analyzer detector (Q-TOF) [Internet]. Latin American Journal of Pharmacy. 2014 ; 33( 5): 717-724.[citado 2024 nov. 08 ] Available from: http://www.latamjpharm.org/resumenes/33/5/LAJOP_33_5_1_2.pdf